We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Science and Technology Award for TMT at HUPO World Congress
News

Science and Technology Award for TMT at HUPO World Congress

Science and Technology Award for TMT at HUPO World Congress
News

Science and Technology Award for TMT at HUPO World Congress

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Science and Technology Award for TMT at HUPO World Congress"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Proteome Sciences is delighted that HUPO (Human Proteome Organisation) has announced that the Science and Technology Award for the commercialisation of isobaric mass tagging technologies, including our TMT® isobaric mass tags for labelling samples in mass spectrometers, is to be presented at the forthcoming HUPO World Congress in Madrid. Dr Andrew Thompson, Head of Chemical Proteomics at Proteome Sciences is amongst the team being honoured.  Dr Thompson was an original inventor of TMT® proteomics and he has also worked on the application of isobaric tags in genomics and MALDI imaging.  

Dr Ian Pike, Chief Operating Officer commented:

“This award from HUPO to the team leading the commercial development of TMT® is a welcome recognition of the innovation that Proteome Sciences plc has brought to the field of proteomics.

Over the last six years we have developed the largest portfolio of TMT® isobaric tagging reagents for a wide range of biological experiments.  TMT® 10-plex provides the highest multiplexing capability currently available and we will continue to deliver new reagents that further expand the range of tags.

Using sophisticated TMT® workflows we are able to offer our clients the same level of innovation in our proteomics discovery and validation services through SysQuant® for cell signalling pathway analysis and TMT®-MS3 for high-throughput plasma and CSF proteomics.”

Advertisement